FDA Inspection 1325630 — Dr. Andrea Di Cianni
The FDA completed an inspection of Dr. Andrea Di Cianni on June 11, 2026 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Buenos Aires (Argentina)
Additional Details
Clinical BA/BE